ORAMED PHARMACEUTICALS INC.
Company Information
Industry
Pharmaceutical Preparations
SIC Code
2834
Entity Type
operating
SEC Category
Non-accelerated filerSmaller reporting company
State of Incorporation
DE
Business Address
1185 AVENUE OF THE AMERICAS, 3RD FLOOR, NEW YORK, NY, 10036
Mailing Address
1185 AVENUE OF THE AMERICAS, 3RD FLOOR, NEW YORK, NY, 10036
Phone
646-844-1164
Fiscal Year End
1231
EIN
980376008
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| 4 Insider stock transaction report | March 31, 2026 | View on SEC |
| 4 Insider stock transaction report | March 31, 2026 | View on SEC |
| 8-K Current report of material events | March 31, 2026 | View on SEC |
| 10-K Annual financial report | March 26, 2026 | View on SEC |
| 4 Insider stock transaction report | March 18, 2026 | View on SEC |
| 4 Insider stock transaction report | March 18, 2026 | View on SEC |
| 4 Insider stock transaction report | March 18, 2026 | View on SEC |
| 4 Insider stock transaction report | March 18, 2026 | View on SEC |
| 4 Insider stock transaction report | March 16, 2026 | View on SEC |
| 8-K Current report of material events | February 20, 2026 | View on SEC |
Annual Reports
10-K
March 26, 2026
- Developing a proprietary POD™ platform to enable oral delivery of injectable medications.
- Transitioning to a hybrid business model that leverages investment returns to fund drug research.
Material Events
8-K
Strategy Change
March 31, 2026
High Impact
- Divestiture of Oratech Pharma to Lifeward to streamline operations
- Strategic pivot to focus capital and management on ORMD-0801 insulin capsule
Related Companies
Companies in the same industry (SIC: 2834)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.